Philp, D., Badamchian, M., Scheremeta, B., Nguyen, M., Goldstein, A
Clinical Trial Evidence & Failure The definitive human evidence for AOD-9604 comes from a Phase 2b double-blind, placebo-controlled trial published by Stier et al
Human GRP78 activity has also been shown in vitro to be upregulated by its posttranslational modification with cell filamentation protein (FIC) (Sanyal et al., 2015)
The STEP 1 clinical trial showed that participants began seeing measurable weight reduction within the first 4 to 8 weeks of treatment
(11) Another interesting observation was the considerable improvement in brain edema, swelling in the brain tissue often caused by traumatic injuries
Loeys-Dietz syndrome